IP Library › Granted Patent US 11,759,545
Granted Patent B2
US 11,759,545 · App. 17/393,299 · Granted Sep 19, 2023

Polymer particles

Inventors: Gloria Hincapie (Aliso Viejo, CA); Xinping Wu (Aliso Viejo, CA); Yue Wu (Aliso Viejo, CA); Gregory M. Cruise (Rancho Santa Margarita, CA)
Assignee: Terumo Corporation
A61L24/0015A61K31/4745A61K31/555A61K47/6927A61L24/0042A61L24/06A61L26/009A61L26/0014A61L26/0061A61L31/048A61L31/148C08F220/56C08F236/20A61B17/12109A61B17/12113A61B17/12181A61B2017/00004A61L2300/204A61L2300/224A61L2400/06A61L2430/36
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,759,545
App. No.
17/393,299
Granted
Sep 19, 2023
Kind
B2
Abstract

Biodegradable, cross-linked polymer particle embolics and methods of making the same are described. The particle embolics can be used as embolization agents.

Claims (23)

1. A plurality of polymer particles comprising:

a reaction product of a prepolymer solution including a solvent, at least one monomer, and at least one crosslinker having a structure

2. The polymer particles of claim 1 having a diameter between about 40 μm and about 1,200 μm.

3. The polymer particles of claim 1 having a diameter between about 75 μm and about 1,200 μm.

4. The polymer particles of claim 1 , wherein the at least one monomer includes at least one functional group.

5. The polymer particles of claim 4 , wherein the at least one functional group is acrylate, acrylamide, methacrylate, or methacrylamide.

6. The polymer particles of claim 1 , wherein the at least one monomer includes an ionizable functional group.

7. The polymer particles of claim 1 , wherein the prepolymer solution further includes a second crosslinker including a second linkage selected from an ester, a thioester, a carbonate, a peptide cleavable by matrix metalloproteinases, a peptide cleavable by matrix collagenases, a peptide cleavable by matrix elastases, and a peptide cleavable by matrix cathepsins.

8. The polymer particles of claim 1 , wherein the polymer particles are biodegradable.

9. The polymer particles of claim 1 , wherein the polymer particles are biostable.

10. The polymer particles of claim 1 , wherein the at least one monomer is dimethylacrylamide.

11. The polymer particles of claim 1 , wherein the at least one monomer is acrylamide.

12. The polymer particles of claim 1 , wherein the crosslinker is

13. The polymer particles of claim 1 , wherein the crosslinker is

14. The polymer particles of claim 1 , wherein the crosslinker is

15. The polymer particles of claim 1 , wherein the crosslinker is

16. The polymer particles of claim 1 , wherein the crosslinker is

17. The polymer particles of claim 1 , wherein the crosslinker is

18. The polymer particles of claim 1 , wherein the crosslinker is

19. A method of treating a vascular condition, the method comprising:

delivering the plurality of polymer particles of claim 1 to a vessel in need thereof.

20. A method of forming the polymer particles, the method comprising:

reacting the prepolymer solution of claim 1 to form the polymer particles.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 3, 2021
From: HINCAPIE, GLORIA; WU, XINPING; WU, YUE; CRUISE, GREGORY M.
To: MICROVENTION, INC.
Reel/Frame 057071/0845 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 3, 2021
From: MICROVENTION, INC.
To: TERUMO CORPORATION
Reel/Frame 057071/0860 →
Continuity (6)
Continuation 16821783 · Mar 17, 2020
Continuation 16237298 · Dec 31, 2018
Continuation 15719241 · Sep 28, 2017
Provisional Application 62428990 · Dec 1, 2016
Provisional Application 62401091 · Sep 28, 2016
Related Publication 20210361823A1 · Nov 25, 2021
Cited By (2)
US 12,364,786 US 12,447,228